Abstract
An autoimmune disorder is the body’s reaction to an unknown stimulus causing the overproduction of antibodies that are directed against body tissue (Wallace, 1995). Although most autoimmune diseases are associated with significant and chronic morbidity and disability, epidemiological studies are generally limited to a few of the more prevalent disorders such as rheumatoid arthritis or diabetes mellitus. Recent estimates indicate that 1 in 31 individuals in the United States currently are diagnosed with an autoimmune disease, with women at higher risk than men (Jacobson, Gange, Rose, & Graham, 1997).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alarcon-Segovia, D. (1988). Systemic lupus erythematosus: Pathology and pathogenesis. In H. R.Schumacher, Jr., J. H. Kippel, & D. R. Robinson (Eds.), Primer on the rheumatic diseases (pp. 96–99). Atlanta, GA: Arthritis Foundation.
Alexander, E. L. (1986a). Central nervous system (CNS) manifestations of primary Sjögren’s syndrome:An overview. Scandinavian Journal of Rheumatology, 62(Suppl.), 161–165.
Alexander, E. L. (1986b). Immunopathologic mechanisms of inflammatory vascular disease in primary Sjögren’s syndrome-A model. Scandinavian Journal of Rheumatology, 61(Suppl.), 280–285.
Alexander, E. L. (1986c). Neuromuscular complications of primary Sjögren’s syndrome. In N. Talal, H.M. Moutsopoulos, & S. Kassan (Eds.), Sjögren’s syndrome: Clinical and immunological aspects (pp.61–82). Heidelburg: Springer-Verlag.
Alexander, E. L. (1992). Central nervous system disease in Sjögren’s syndrome: New insights into immunopathogenesis. Rheumatic Disease Clinics of North America, 3, 637–672.
Alexander, E. L. (1993). Neurologic disease in Sjögren’s syndrome: Mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. Rheumatic Disease Clinics of North America, 19, 869–908.
Alexander, E. L., Provost, T. T., Stevens, M. B., & Alexander, G. E. (1982). Neurologic complications of primary Sjögren’s syndrome. Medicine, 61, 247–257.
Alexander, E. L., Lijewski, J. E., Jerdan, M. S., & Alexander, G. E. (1986a). Evidence of an immunopathogenic basis for central nervous system disease in primary Sjögren’s syndrome. Arthritis and Rheumatism, 29, 1223–1231.
Alexander, E. L., Malinow, K., Lejewski, J. E., Jerdan, M. S., Provost, T. T., & Alexander, G. E. (1986b).Primary Sjögren’s syndrome with central nervous system disease mimicking multiple sclerosis.Annals of Internal Medicine, 104, 323–330.
Alexander, E. L., Beall, S. S., Gordon, B., Seines, O. A., Yannakakis, G. D., Patronas, N., Provost, T. T., & McFarland, H. F. (1988). Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome.Annals of Internal Medicine, 108, 815–823.
Andonopoulos, A. P., Lagos, G., Drosos, A. A., & Moutsopoulos, H. M. (1990). The spectrum of neuro-logical involvement in Sjögren’s syndrome. British Journal of Rheumatology, 29, 21–23.
Asherson, R. A., & Hughes, G. R. V. (1988). Systemic lupus erythematosus: Clinical features. In H. R.Schumacher, Jr., J. H. Kippel, & D. R. Robinson (Eds.), Primer on the rheumatic diseases (pp. 100–106). Atlanta, GA: Arthritis Foundation.
Bansal, S. K., Sawhney, I. M. S., & Chopra, J. S. (1987). Epilepsia partialis continua in Sjögren’s syndrome. Epilepsia, 28, 362–363.
Beers, S. R., Morrow, L. M., Ryan, C. M., Wasko, M. C., Rarie, J., & Manzi, S. (1996). Use of information processing measures to detect cognitive deficits in systemic lupus erythematosus. Journal of the International Neuropsychological Society, 2, 54.
Berman, H. M., & Blumenfeld, M. M. (1992). Psychiatric symptoms in systemic lupus erythematosus.Journal of Musculoskeletal Medicine, 9(6), 81–94.
Binder, A., Snaith, M. L., & Isenberg, D. (1988). Sjögren’s syndrome: A study of its neurological complications. British Journal of Rheumatology, 27, 275–280.
Boumpas, D. T., Fessler, B. J., Austin, H. A., Balow, J. E., Klippel, J. H., & Lockshin, M. D. (1995).Systemic lupus erythematosus: Emerging concepts. Annals of Internal Medicine, 123, 42–53.
Breitbach, S. A., Alexander, R. W., Daltroy, L. H., Liang, M. H., Boll, T. J., Karlson, E. W., Partiridge, A. J.,Roberts, W. N., Stern, S. H., Wacholtz, M. C., & Straaton, K. V. (1998). Determinants of cognitive performance in systemic lupus erythematosus. Journal of Clinical and Experimental Neuropsychology, 20, 157–166.
Bresnihan, B., & O’Connell, A. (1982). Systemic lupus erythematosus, cerebral disease, and intellectual function. Arthritis and Rheumatism, 25(Suppl.), S82.
Calabrese, L. V., & Stern, T. A. (1995). Neuropsychiatric manifestations of systemic lupus erythema-tosus. Psychosomatics, 36, 344–359.
Carbotte, R. M., Denburg, S. D., & Denburg, J. A. (1984). Cognitive dysfunction and systemic lupuserythematosus. In R. G. Lahita (Ed.), Systemic lupus erythematosus (pp. 865–881). New York:Churchill Livingstone.
Carbotte, R. M., Denburg, S. D., & Denburg, J. A. (1986). Prevalence of cognitive impairment in systemic lupus erythematosus. Journal of Nervous and Mental Disease, 174, 357–364.
Carbotte, R. M., Denburg, S. D., & Denburg, J. A. (1995a). Cognitive deficit associated with rheumatic diseases: Neuropsychological perspectives.Arthritis and Rheumatism, 38, 1363–1374.
Carbotte, R. M., Denburg, S. D., & Denburg, J. A. (1995b). Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. Journal of Rheumatology, 22, 863–867.
Caselli, R. J., Scheithauer, B. W., Bowles, C. A., Trenerry, M. R., Meyer, F. B., Smigielski, J. S., & Rodri-guez, M. (1991). The treatable dementia of Sjögren’s syndrome. Annals of Neurology, 30, 98–101.
Centers for Disease Control. (1991). Eosinophilia-myalgia syndrome: Follow-up survey of patients-New York, 1990–1991. Morbidity and Mortality Weekly Report, 40, 401–403.
Costallat, L. T. L., & Coimbra, A. M. V. (1994). Systemic lupus erythematosus: Clinical and laboratory aspects related to age at disease onset. Clinical and Experimental Rheumatology, 12, 603–607.
Creange, A., Sedel, F., Brugieres, P., Voisin, M. C., & Degos, J. D. (1997). Primary Sjögren’s syndrome presenting as progressive Parkinsonian syndrome. Movement Disorders, 12, 121–123.
Daniels, T. E. (1996). Sjögren’s syndrome: Clinical spectrum and current diagnostic controversies.Advances of Dental Research, 10, 3–8.
Daniels, T. E., & Talal, N. (1987). Diagnosis and differential diagnosis of Sjögren’s syndrome. In N. Talal,H. M. Moutsopoulos, & S. Kassan (Eds.), Sjögren’s syndrome: Clinical and immunological aspects (pp. 193–199). Heidelberg: Springer-Verlag.
Darby, P. L., & Schmidt, P. J. (1988). Psychiatric consultations in rheumatology: A review of 100 cases.Canadian Journal of Psychiatry, 33, 290–293.
Denburg, J. A., Carbotte, R. M., & Denburg, S. D. (1987a). Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology, 37, 464–467.
Denburg, S. D., Carbotte, R. M., & Denburg, J. A. (1987b). Cognitive impairment in systemic lupus erythematosus: A neuropsychological study of individual and group deficits. Journal of Clinical and Experimental Neuropsychology, 4, 323–339.
Denburg, S. D., Carbotte, R. M., Ginsberg, J. S., & Denburg, J. A. (1997). The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. Journal of the International Neuropsychological Society, 3, 377–386.
Denburg, S. D., Carbotte, R. M., & Denburg, J. A. (1999). Identifying cognitive deficits in systemic lupus erythematosus. Journal of Musculoskeletal Medicine, 16, 356–363.
Dennis, M. S., Bryne, E. J., Hopkinson, N., & Bendall, P. (1992). Neuropsychiatric systemic lupus erythematosus in elderly people: A case series. Journal of Neurology, Neurosurgery, and Psychi-atry, 55, 1157–1161.
Drosos, A. A., Andonopoulos, A. P., Lagos, G., Angelopoulos, N. V., & Moutsopoulos, H. M. (1989).Neuropsychiatric abnormalities in primary Sjögren’s syndrome. Clinical and Experimental Rheu-matology, 7, 207–209.
Dubois, E. L., & Tuffanelli, D. L. (1964). Clinical manifestations of systemic lupus erythematosus.Journal of the American Medical Association, 190, 104–111.
Eisenberg, R. A., & Cohen, P. L. (1988). The role of immunologic mechanisms in the pathogenesis of rheumatic diseases. In H. R. Schumacher, Jr., J. H. Kippel, & D. R. Robinson (Eds.), Primer on rheumatic diseases (pp. 36–44). Atlanta, GA: Arthritis Foundation.
Ferstl, R., Niemann, T., Biehl, G., Hinrichsen, H., & Kirch, W. (1992). Neuropsychological impairment in auto-immune disease. European Journal of Clinical Investigation, 22(Suppl. 1), 16–20.
Fisk, J. D., Eastwood, B., Sherwood, G., & Hanly, J. G. (1993). Patterns of cognitive impairment in patients with systemic lupus erythematosus. British Journal of Rheumatology, 32, 458–462.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). A practical method for grading the cognitive state of patients for the clinician.Journal of Psychiatry Research, 12, 189–198.
Giang, D. W. (1991). Systemic lupus erythematosus and depression. Neuropsychiatry, Neuropsychology,and Behavioral Neurology, 4, 78–82.
Ginsburg, K. S., Wright, E. A., Larson, M. G., Gossel, A. H., Albert, M., Schur, P. H. J., & Liang, M. H.(1992). A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis and Rheumatism, 35, 776–782.
Glanz, B. I., Slonim, D., Urowitz, M. B., Gladman, D. D., Grough, J., Math, M., & MacKinnon, A. (1997).Pattern of neuropsychological dysfunction in inactive systemic lupus erythematosus.Neuropsy-chiatry, Neuropsychology, and Behavioral Neurology, 10, 232–238.
Grant, I., Heaton, R. K., & Marcotte, T. D. (1997). Evaluating the neurocognitive complications of SLE.In P. M. Moore & R. G. Lahita (Eds.), Neuropsychiatric manifestations of systemic lupus erythema-tosus (pp. 18–43). New York: New York Academy of Sciences.
Hanly, J. G., Fisk, J. D., Sherwood, G., Jones, E., Verrier Jones, J., & Eastwood, B. (1992). Cognitive impairment in patients with systemic lupus erythematosus. Journal of Rheumatology, 19,562–567.
Hanly, J. G., Fisk, J. D., Sherwood, G., & Eastwood, B. (1994). Clinical course of cognitive dysfunction in systemic lupus erythematosus. Journal of Rheumatology, 21, 1825–1831.
Hay, E. M., Huddy, A., Creed, F., Tomenson, R., & Bernstein, R. M. (1992). Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis and Rheumatism, 35, 411–416.
Hay, E. M., Huddy, A., Black, D., Mbaya, P., Tomenson, R., Bernstein, R. M., Holt, P. J. L., & Creed, F.(1994). A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Annals of Rheumatic Disease, 53, 298–303.
Hietaharju, A., Yli-Kerttula, U., Hakkinen, V., & Frey, H. (1990). Nervous system manifestations in Sjögren’s syndrome. Acta Neurologica Scandinavica, 81, 144–152.
Hochberg, M. C., Perlmutter, D. L., White, B., Medsger, T. A., Steen, V., Weisman, M., & Wigley, F. M.(1994). The prevalence of self-reported physician diagnosed systemic lupus erythematosus (Ab-stract). Arthritis and Rheumatism, 38, S302.
Jacobson, D. L., Gange, S. J., Rose, N. R., &Graham, M. H. (1997). Epidemiology and estimated population burden of selected autoimmune diseases in the United States.Clinical Immunology and Immunopathology, 84,223–243.
Jonsson, H., Nived, O., Sturfelt, G., &Silman, A. (1990). Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval.British Journal of Rheumatology, 29,185–188.
Julian, L. J., &Kozora, E. (1995). Verbal learning and recall in patients with systemic lupus erythemato-sus (SLE) compared to rheumatoid arthritis (RA) and normal controls.Archives of Neuropsychol-ogy, 10,347–348.
Kamb, M. L., Murphy, J. J., Jones, J. L., Caston, J. C., Nederlof, K., Horney, L. F., Swygert, L. A., Falk, H., & Kinsbourne, E. M. 1992. Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients.Jour-nal of the American Medical Association, 276(1), 77–82.
Kardestuncer, T. &Frumkin, H. (1997). Systemic lupus erythematosus in relation to environmental pollution: An investigation in an African-American community in north Georgia.Archives of Environmental Health, 52(2), 85–90.
Kaufman, L. D. (1992). The eosinophilia-myalgia syndrome: Current concepts and future directions.Clinical and Experimental Rheumatology, 10,87–91.
Kozora, E., Thompson, L. L., West, S. G., &Kotzin, B. L. (1996). Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease.Arthritis and Rheumatism, 39, 2035–2045.
Krupp, L. B., Pepper, C., Jandorf, L., &Kaufman, L. (1992). Central nervous system involvement in eosinophilia-myalgia syndrome.Neurology, 42(Suppl. 3), 294.
Krupp, L. B., Mansur, D. M., &Kaufman, L. D. (1993). Neurocognitive dysfunction in the eosinophilia-myalgia syndrome.Neurology, 43,931–936.
Kushner, M. J., Tobin, M., Fazekas, F., Chawluk, J., Jamieson, D., Freundlich, B., Grenell, S., Freeman, L.,&Reivich, M. (1990). Cerebral blood flow variations in CNS lupus.Neurology, 40,99–102.
Kutner, K. C., Busch, H. M., Mahmood, T., Racis, S. P., &Krey, P. R. (1988). Neuropsychological functioning in systemic lupus erythematosus.Neuropsychology, 2,119–126.
Lim, L., Ron, M. A., Ormerod, I. E. C., David, J., Miller, D. H., Logsdail, S. J., Walport, M. J., &Harding,A. E. (1988). Psychiatric and neurological manifestations in systemic lupus erythematosus.Quar-terly Journal of Medicine, New Series 66, 249, 27–38.
Lynn, J., Rammohan, K. W., Bornstein, R. A., &Kissel, J. T. (1992). Central nervous system involvement in the eosinophilia-myalgia syndrome.Archives of Neurology, 49,1082–1085.
Malinow, K. L., Molina, R., Gordon, B., Seines, O. A., Provost, T. T., &Alexander, E. L. (1985).Neuropsychiatric dysfunction in primary Sjögren’s syndrome.Annals of Internal Medicine, 103,344–349.
Martin, R. W., Duffy, J., Engle, A. G., Lie, J. T., Bowles, C. A., Moyer, T. P., &Gleich, G. J. (1990). The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.Annals of Internal Medicine, 113,124–134.
McCune, W. J., Golbus, J., Zeldes, W., Bohlke, P., Dunne, R., &Fox, D. A. (1988a). Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe sys-temic lupus erythematosus.New England Journal of Medicine, 318,1423–1431.
McCune, W. J., MacGuire, A., Aisen, A., &Gebarski, S. (1988b). Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning.Arthritis and Rheumatism, 31,159–166.
Mellgren, S. I., Conn, D. L., Stevens, J. C., &Dyck, P. J. (1989). Peripheral neuropathy in primary Sjögren’s syndrome.Neurology, 39,390–394.
Moore, P. M., &Lahita, R. G. (Eds.). (1997).Neuropsychiatric manifestations of systemic lupus erythematosus. New York: New York Academy of Sciences.
Moskowitz, N. (1989). Systemic lupus erythematosus of the central nervous system: Molecular theories and models for mental disease.Mt. Sinai Journal of Medicine, 56,23–29.
Moutsopoulos, H. M., Sarmas, J. H., &Talal, N. (1993). Is central nervous system involvement a systemic manifestation of primary Sjögren’s syndrome?Rheumatic Disease Clinics of America, 19,909–912.
Newman, S. P. (1993). Cognitive changes in systemic lupus erythematosus.Bailliere’s Clinical Rheuma-tology, 65,622–627.
Nossent, J. C., Hovestadt, A., Schonfeld, D. H. W., &Swaak, A. J. G. (1991). Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus.Arthritis and Rheumatism,34,1397–1403.
O’Conner, P. (1988). Diagnosis of central nervous system lupus.Canadian Journal of Neurological Science, 15,257–260.
Ohtsuka, T., Saito, Y., Hasegawa, M., Tatsuno, M., Takita, S., Arita, M., &Okuyama, K. (1995). Central nervous system disease in a child with primary Sjögren syndrome.Journal of Pediatrics, 127,961–963.
Olney, R. K. (1992). AAEM Minimonograph #38: Neuropathies in connective tissue disease.Muscle and Nerve, 15,531–542.
Pachman, L. M., &Haugen, M. S. (1988). Pediatric rheumatic diseases: Other pediatric rheumatic diseases. In H. R. Schumacher, Jr., J. H. Klippel, &D. R. Robinson (Eds.),Primer on the rheumatic diseases(pp. 164–170). Atlanta: Arthritis Foundation.
Petri, M. (1995). Clinical features of systemic lupus erythematosus.Current Opinion in Rheumatology,7,395–401.
Pierot, L., Sauve, C., Leger, J. M., Martin, N., Koeger, A. C., Wechsler, B., &Chiras, J. (1993). Asympto-matic cerebral involvement in Sjögren’s syndrome: MRI findings of 15 cases.Neuroradiology, 35(5),378–380.
Pinching, A. J., Travers, R. L., Hughes, G. R. V., Jones, T., &Moss, S. (1978). Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus.Lancet, 6,898–900.
Pincus, T., Clauw, D., Hertzman, P., Kaufman, L., Silver, R., Varga, J., &Callahan, L. F. (1993). 18-24 month structured follow-up of 210 patients with eosinophilia-myalgia syndrome in 12 states.Arthritis and Rheumatism, 36(Suppl. 9), S130.
Quismorio, F. P., Jr. (1993). Cardiac abnormalities in systemic lupus erythematosus. In D. J. Wallace &B. H. Hahn (Eds.),Dubois’ lupus erythematosus(pp. 332–342). Philadelphia: Lea &Febiger.
Reeves, W. H., &Lahita, R. G. (1984). Clinical presentation of systemic lupus erythematosus in the adult.In R. G. Lahita (Ed.),Systemic lupus erythematosus(pp. 369–396). New York: Churchill Liv-ingstone.
Ruddy, S. (1988). The complement system. In H. R. Schumacher, Jr., J. H. Kippel, &D. R. Robinson (Eds.),Primer on rheumatic diseases (pp. 30–32). Atlanta: Arthritis Foundation.
Schneebaum, A. B., Singleton, J. D., West, S. G., Blodgett, J. K., Allen, L. G., Cheronis, J. C., &Kotzin, B.L. (1991). Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.American Journal of Medicine, 90,54–62.
Seines, O. A., Gordon, B., Malinow, K. L., &Alexander, E. L. (1985). Cognitive dysfunction in primary Sjögren’s syndrome.Neurology, 35(Suppl 1), 179.
Shoenfeld, Y. (1984). Autoimmunity and autoimmune diseases like systemic lupus erythematosus. In R. G. Lahita (Ed.),Systemic lupus erythematosus(pp. 3–14). New York: Churchill Livingstone.
Sibler, T. J., Chatoor, I., &White, R. H. (1984). Psychiatric manifestations of systemic lupus erythema-tosus in children and adolescents.Clinical Pediatrics, 23,331–335.
Silverman, E. D., &Laxer, R. M. (1997). Neonatal lupus erythematosus.Rheumatic Diseases Clinics of North America, 23,599–618.
Steinlin, M. I., Blaser, S. I., Gilday, D. L., Eddy, A. A., Logan, W. J., Laxer, R. M., &Silverman, E. D. (1995).Neurologic manifestations of pediatric systemic lupus erythematosus.Pediatric Neurology, 13,191–197.
Swygert, L. A., Maes, E. F., Sewell, L. E., Miller, L., Falk, H., Kilboune, E. M. (1990). Eosinophilia-myalgia syndrome: Results of national surveillance.Journal of the American Medical Association,264,1698–1703.
Szer, I. S., Miller, J. H., Rawlings, D., Shaham, B., &Bernstein, B. (1993). Cerebral perfusion abnor-malities in children with central nervous system manifestations of lupus detected by single photon emission computed tomography.Journal of Rheumatology, 20,2143–2148.
Tajima, Y., Mito, Y., Owada, Y., Tsukishima, E., Moriwaka, F., &Tashiro, K. (1997). Neurological manifestations of primary Sjögren’s syndrome in Japanese patients.Internal Medicine, 36,690–693.
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., &Rothfield, N. F. (1982). The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis and Rheumatism, 25,1271–1277.
Tarter, R. E., Hays, A. L., Carra, J., Edwards, K. L., &Van Thiel, D. H. (1989). Sjögren’s syndrome: Its contribution to neuropsychiatric syndrome in patients with primary biliary cirrhosis.Digestive Diseases and Science, 34,9–12.
Tolander, L. M., Bamford, C. R., Yoshino, M. T., Downing, S., &Byran, G. (1991). Neurologic complica-tions of the tryptophan-associated eosinophilia-myalgia syndrome.Archives of Neurology, 48,436–438.
Vitali, C., Bombardieri, S., Moutsopoulos, H. M., Coll, J., Gerli, R., Hatron, P. Y., Kater, L., Konttinen, Y.T., Manthorpe, R., Meyer, O., Mosca, M., Ostuni, P., Pellerito, R. A., Pennec, Y., Porter, S. R.,Richards, A., Sauvezie, B., Schiodt, M., Shoenfeld, Y., Skopouli, F. N., Smolen, J. S., Soromenho, F.,Tishler, M., Tomsic, M., van de Merle, J. P., Yeoman, C. M., &Wattiaux, M. J. (1996). Assessment of the European classification criteria for Sjögren’s syndrome in a series of clinically defined cases:Results of a prospective multicenter study.Annals of the Rheumatic Diseases, 55(2),116–121.
Wallace, D. J. (1995).The lupus book.New York: Oxford University Press.
Wallace, D. J., Podell, T., Weiner, J., Klineberg, J. R., Forouzesh, S., &Dubois, E. L. (1981). Systemic lupus erythematosus-Survival patterns.Journal of the American Medical Association, 245,934–938.
Wekking, E. M., Nossent, J. C., van Dam, A. P., &Swaak, A. J. J. G. (1991). Cognitive and emotional disturbances in systemic lupus erythematosus. Psychotherapy and Psychosomatics, 55, 126–131.
Williamson, B. L., Klarskov, K., Tomlinson, A. J., Gleich, G. J., &Naylor, S. (1998). Problems with over-the-counter 5-hydroxy-L-tryptophan.Nature Medicine, 4, 983.
Wykoff, P. M., Miller, L. C., Tucker, L. B., &Schaller, J. G. (1995). Neuropsychological assessment of children and adolescents with systemic lupus erythematosus.Lupus, 4,217–220.
Yancey, C. L., Doughty, R. A., &Athreya, B. H. (1981). Central nervous system involvement in childhood systemic lupus erythematosus.Arthritis and Rheumatism, 24,1389–1395.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Beers, S.R. (2001). Systemic Autoimmune Disease. In: Tarter, R.E., Butters, M.A., Beers, S.R. (eds) Medical Neuropsychology. Critical Issues in Neuropsychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1287-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1287-5_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5479-6
Online ISBN: 978-1-4615-1287-5
eBook Packages: Springer Book Archive